(NYSE: BSX) Boston Scientific's forecast annual revenue growth rate of 12.35% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Boston Scientific's revenue in 2025 is $16,747,000,000.On average, 9 Wall Street analysts forecast BSX's revenue for 2025 to be $28,765,316,337,935, with the lowest BSX revenue forecast at $28,681,747,451,240, and the highest BSX revenue forecast at $28,884,814,518,350. On average, 9 Wall Street analysts forecast BSX's revenue for 2026 to be $31,806,523,114,197, with the lowest BSX revenue forecast at $31,434,073,615,200, and the highest BSX revenue forecast at $32,158,680,664,264.
In 2027, BSX is forecast to generate $35,111,581,306,117 in revenue, with the lowest revenue forecast at $34,364,968,929,744 and the highest revenue forecast at $35,815,658,805,976.